You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The in vitro diagnostic test runs on the Illumina NovaSeq 6000 instrument and will be performed at Helix's San Diego CLIA-certified laboratory.
The company said it has also received Emergency Use Authorization from the US Food and Drug Administration for its nucleic acid extraction kit.
The partners will specifically integrate Gilson's Trackman Connected digital bench tools and Qiagen's manual nucleic acid extraction kits.
S2 Genomics' Singulator platform combines enzymatic and mechanical disruption to produce suspensions of cells or nuclei for downstream applications.
The new firm will offer target enrichment assays for clinical NGS testing and develop library preparation kits for clinical tests on Illumina's sequencing platform.
The firm's tool combines enzymatic and mechanical disruption to produce viable and accurate products for downstream single-cell applications.
The Irvine, California-based firm said its "Revolution" system offer recovery rates of 70 to 90 percent across a wide range of liquid sample volumes.
The deal covers Arcis' line of nucleic acid extraction and preservation products, which enable RNA and DNA preparation in under three minutes.
The firm's technology can perform in-droplet centrifugation, 10-second cell lysis, and sound wave-based PCR on the surface of an inexpensive polymer chip.
The startup, which was founded by two Washington University researchers and a Wharton MBA, is looking to take a big bite out of Cologuard's market.
AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.
Time magazine looks into how liquid biopsies are changing cancer care.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.